These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16038255)

  • 21. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 22. Rifampicin and isoniazid in the treatment of leprous nerve abscesses.
    Husain S; Mishra B; Malaviya GN
    Acta Leprol; 1997; 10(3):147-50. PubMed ID: 9259885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leprosy simulating other diseases].
    López-Vélez R; Sáez Vaquero T; Blanco Arévalo JL; Gómez Mampaso E
    Rev Clin Esp; 1999 Jun; 199(6):369-72. PubMed ID: 10432812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 25. Ulnar abscess: 4 months after release from control with paucibacillary-multidrug therapy.
    Darius EJ; Selvasekar A; Mani MN; Jesudasan K
    Lepr Rev; 1997 Jun; 68(2):173-4. PubMed ID: 9217358
    [No Abstract]   [Full Text] [Related]  

  • 26. Paucibacillary treatment for large tuberculoid lesions of leprosy?
    Santos MN; de Ferreira LC; Talhari S
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):225-7; author reply 227-8. PubMed ID: 16830649
    [No Abstract]   [Full Text] [Related]  

  • 27. Comment on: Arthritis as presenting manifestation of pure neuritic leprosy--a rheumatologist's dilemma.
    Al Attia HM
    Rheumatology (Oxford); 2008 Jan; 47(1):110-1; author reply 111-2. PubMed ID: 18077500
    [No Abstract]   [Full Text] [Related]  

  • 28. Facial reversal reaction: a dermatological emergency.
    Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
    J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reaction in borderline tuberculoid leprosy presenting with multiple subcutaneous nodules.
    Jayakumar J; Aschhoff M; Gomathi A
    Indian J Lepr; 1993; 65(2):239-42. PubMed ID: 8345240
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and histopathological activity in paucibacillary leprosy patients after fixed-duration multidrug therapy.
    Ebenezer GJ; Suneetha S; Arunthathi S
    Lepr Rev; 1997 Sep; 68(3):218-24. PubMed ID: 9364822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyclosporin A treatment in reversal reaction.
    Chin-A-Lien RA; Faber WR; Naafs B
    Trop Geogr Med; 1994; 46(2):123-4. PubMed ID: 8079388
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of relapsed borderline-lepromatous (BL) leprosy following 27 months of multiple drug therapy, Bhutan.
    Reimer DE; Andersen SM
    Lepr Rev; 1995 Jun; 66(2):183. PubMed ID: 7637531
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy trial in paucibacillary leprosy using clofazimine.
    Katoch K; Natarajan M; Katoch VM; Singh HB; Bhatia AS
    Indian J Lepr; 1999; 71(3):311-24. PubMed ID: 10626237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral lesion in leprosy: borderline tuberculoid diagnosis based on detection of Mycobacterium leprae DNA by qPCR.
    da Silva Martinez T; Nahas AA; Figueira MM; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
    Acta Derm Venereol; 2011 Oct; 91(6):704-7. PubMed ID: 21879249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precautionary note for observing signs of activity (or relapse) in treated leprosy patients.
    Ramesh V
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):322-3. PubMed ID: 2071991
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of paucibacillary leprosy.
    Saxena U; Misra RS; Ramesh V
    Int J Dermatol; 1993 Feb; 32(2):135-7. PubMed ID: 8440559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood leprosy: a Pandora's box. A case report of tuberculoid leprosy downgrading to borderline tuberculoid leprosy in a 5-year-old child.
    Bose S
    Int J Dermatol; 2022 Jul; 61(7):e242-e244. PubMed ID: 34783019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.